Li Ju-yun - Net Worth and Insider Trading

Li Ju-yun Net Worth

The estimated net worth of Li Ju-yun is at least $5.5 Billion dollars as of 2025-07-05. Li Ju-yun is the of Ascentage Pharma Group International and owns about 64,585,929 shares of Ascentage Pharma Group International (HKSE:06855) stock worth over $5.5 Billion. Details can be seen in Li Ju-yun's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Li Ju-yun has not made any transactions after 2023-10-27 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data
Unlimited Filters in All-in-One Stock Screener
Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Quick Customer Support
And Much More...

Transaction Summary of Li Ju-yun

To

Li Ju-yun Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Li Ju-yun owns 1 companies in total, including Ascentage Pharma Group International (HKSE:06855) .

Click here to see the complete history of Li Ju-yun’s form 4 insider trades.

Insider Ownership Summary of Li Ju-yun

Ticker Company Transaction Date Type of Owner
HKSE:06855 Ascentage Pharma Group International 2023-10-27

Li Ju-yun Latest Holdings Summary

Li Ju-yun currently owns a total of 1 stock. Li Ju-yun owns 64,585,929 shares of Ascentage Pharma Group International (HKSE:06855) as of October 27, 2023, with a value of $5.5 Billion.

Latest Holdings of Li Ju-yun

Ticker Company Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
HKSE:06855 Ascentage Pharma Group International 2023-10-27 64,585,929 84.80 5,476,886,779

Holding Weightings of Li Ju-yun


Li Ju-yun Form 4 Trading Tracker

According to the SEC Form 4 filings, Li Ju-yun has made a total of 10 transactions in Ascentage Pharma Group International (HKSE:06855) over the past 5 years, including 0 buys and 0 sells. The most-recent trade in Ascentage Pharma Group International is the sale of 0 shares on October 27, 2023, which brought Li Ju-yun around $0.

Insider Trading History of Li Ju-yun

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Li Ju-yun Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Li Ju-yun Ownership Network

Ownership Network List of Li Ju-yun

No Data

Ownership Network Relation of Li Ju-yun

Insider Network Chart


Li Ju-yun Owned Company Details

What does Ascentage Pharma Group International do?

Who are the key executives at Ascentage Pharma Group International?

Li Ju-yun is the of Ascentage Pharma Group International. Other key executives at Ascentage Pharma Group International include 2201 Interest of corporation controlled by you JPMorgan Chase & Co. , 2201 Interest of corporation controlled by you Takeda Pharmaceuticals Company Limited , and 2101 Beneficial owner Takeda Pharmaceuticals International AG .

Ascentage Pharma Group International (HKSE:06855) Insider Trades Summary

Over the past 18 months, Li Ju-yun made no insider transaction in Ascentage Pharma Group International (HKSE:06855). Other recent insider transactions involving Ascentage Pharma Group International (HKSE:06855) include a net sale of 0 shares made by JPMorgan Chase & Co. , a net purchase of 24,307,322 shares made by Takeda Pharmaceuticals Company Limited , and a net purchase of 24,307,322 shares made by Takeda Pharmaceuticals International AG .

In summary, during the past 3 months, insiders sold 0 shares of Ascentage Pharma Group International (HKSE:06855) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Ascentage Pharma Group International (HKSE:06855) were sold and 48,614,644 shares were bought by its insiders, resulting in a net purchase of 48,614,644 shares.

Ascentage Pharma Group International (HKSE:06855)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Ascentage Pharma Group International Insider Transactions

No Available Data

Li Ju-yun Mailing Address

Above is the net worth, insider trading, and ownership report for Li Ju-yun. Currently GuruFocus does not have mailing address information for Li Ju-yun.